Advertisement
CIGI vs NEO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIGI is a StrongBuy and NEO is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CIGI’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).
- CIGI’s FA Score: 0 green, 5 red.
- NEO’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CIGI’s TA Score shows that 4 TA indicator(s) are bullish while NEO’s TA Score has 4 bullish TA indicator(s).
- CIGI’s TA Score: 4 bullish, 3 bearish.
- NEO’s TA Score: 4 bullish, 3 bearish.
Price Growth
CIGI (@Real Estate Development) experienced а -1.24% price change this week, while NEO (@Medical Specialties) price change was +2.92% for the same time period.
The average weekly price growth across all stocks in the @Real Estate Development industry was +2.62%. For the same industry, the average monthly price growth was +5.71%, and the average quarterly price growth was +4.04%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +2.11%. For the same industry, the average monthly price growth was +2.71%, and the average quarterly price growth was -0.52%.
Reported Earning Dates
CIGI is expected to report earnings on Jul 30, 2025.
NEO is expected to report earnings on Jul 30, 2025.
Industries' Descriptions
@Real Estate Development (+2.62% weekly)Activities range from the renovation and re-lease of existing buildings to the purchase of raw land and the sale of developed land or parcels to others. Demand for land development business is driven by GDP growth, employment rates, interest rates, and access to/cost of capital. For individual companies in this industry, proper cost estimation and successful bidding play critical roles in their profitability. Large companies could potentially have greater access to capital, while smaller companies can specialize in a specific geographic area or market niche. CBRE Group, VICI Properties Inc and Brookfield Property Partners L.P. are some of the large companies in this industry.
@Medical Specialties (+2.11% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| CIGI | NEO | CIGI / NEO | |
| Capitalization | 6.12B | 2.01B | 305% |
| EBITDA | 509M | -17.61M | -2,891% |
| Gain YTD | -3.508 | -55.158 | 6% |
| P/E Ratio | 84.65 | 49.50 | 171% |
| Revenue | 4.34B | 592M | 732% |
| Total Cash | 205M | 415M | 49% |
| Total Debt | 2.14B | 612M | 349% |
CIGI | NEO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 26 | 13 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 73 Overvalued | |
PROFIT vs RISK RATING 1..100 | 40 | 100 | |
SMR RATING 1..100 | 63 | 93 | |
PRICE GROWTH RATING 1..100 | 49 | 65 | |
P/E GROWTH RATING 1..100 | 67 | 100 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NEO's Valuation (73) in the Medical Or Nursing Services industry is in the same range as CIGI (93) in the Real Estate Development industry. This means that NEO’s stock grew similarly to CIGI’s over the last 12 months.
CIGI's Profit vs Risk Rating (40) in the Real Estate Development industry is somewhat better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that CIGI’s stock grew somewhat faster than NEO’s over the last 12 months.
CIGI's SMR Rating (63) in the Real Estate Development industry is in the same range as NEO (93) in the Medical Or Nursing Services industry. This means that CIGI’s stock grew similarly to NEO’s over the last 12 months.
CIGI's Price Growth Rating (49) in the Real Estate Development industry is in the same range as NEO (65) in the Medical Or Nursing Services industry. This means that CIGI’s stock grew similarly to NEO’s over the last 12 months.
CIGI's P/E Growth Rating (67) in the Real Estate Development industry is somewhat better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that CIGI’s stock grew somewhat faster than NEO’s over the last 12 months.
| CIGI | NEO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 59% | N/A |
| Stochastic ODDS (%) | 2 days ago 66% | 2 days ago 81% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 77% |
| MACD ODDS (%) | 2 days ago 69% | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 76% |
| TrendMonth ODDS (%) | 2 days ago 68% | 2 days ago 75% |
| Advances ODDS (%) | 3 days ago 70% | 2 days ago 78% |
| Declines ODDS (%) | N/A | 7 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 53% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 65% | 2 days ago 75% |
Advertisement
CIGI and
Correlation & Price change
A.I.dvisor indicates that over the last year, CIGI has been closely correlated with JLL. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CIGI jumps, then JLL could also see price increases.
| Ticker / NAME | Correlation To CIGI | 1D Price Change % | ||
|---|---|---|---|---|
| CIGI | 100% | +0.39% | ||
| JLL - CIGI | 78% Closely correlated | +0.43% | ||
| CBRE - CIGI | 78% Closely correlated | +1.07% | ||
| NMRK - CIGI | 75% Closely correlated | +1.23% | ||
| CWK - CIGI | 69% Closely correlated | +2.89% | ||
| FSV - CIGI | 68% Closely correlated | +0.61% | ||
More | ||||